* Aethlon Medical Inc AEMD.OQ AEMD.O is expected to show
a
rise in quarterly revenue when it reports results on June 22
(estimated).
* The San Diego California-based company is expected to
report a
2,020.6% increase in revenue to $721 thousand from $34 thousand
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Aethlon Medical Inc
is
for a loss of 14 cents per share. For the same quarter last
year, the company reported a loss of 15 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $8, above its last closing price of $0.96.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.13 -0.13 -0.16 Missed -23.1
Sep. 30 2021 -0.17 -0.15 -0.13 Beat 13.3
Jun. 30 2021 -0.13 -0.13 -0.16 Missed -23.1
Mar. 31 2021 -0.19 -0.20 -0.15 Beat 23.7
Dec. -0.17 -0.16 -0.20 Missed -21.2
31 2020
Sep. 30 2020 -0.12 -0.12 -0.15 Missed -25
Mar. 31 2020 -0.16 -0.16 -0.22 Missed -36.2
This summary was machine generated June 20 at 20:17 GMT. All
figures in US dollars unless otherwise stated